SARS-CoV-2 Vaccination in Children and Adolescents—A Joint Statement of the European Academy of Paediatrics and the European Confederation for Primary Care Paediatricians

Stopping the COVID-19 pandemic and its socio-economic consequences is only possible with a multifaceted strategy, including mass vaccination. Studies have been conducted mainly in adults, and data on the pediatric population is relatively limited. However, it appears that vaccination in children and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dembiński, Łukasz, Vieira Martins, Miguel, Huss, Gottfried, Grossman, Zachi, Barak, Shimon, Magendie, Christine, del Torso, Stefano, Dornbusch, Hans Jürgen, Mazur, Artur, Albrecht, Katarzyna, Hadjipanayis, Adamos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419337/
https://www.ncbi.nlm.nih.gov/pubmed/34497784
http://dx.doi.org/10.3389/fped.2021.721257
Descripción
Sumario:Stopping the COVID-19 pandemic and its socio-economic consequences is only possible with a multifaceted strategy, including mass vaccination. Studies have been conducted mainly in adults, and data on the pediatric population is relatively limited. However, it appears that vaccination in children and adolescents is highly effective and safe. Despite the apparent benefits of vaccinating this age group, there are some medical and ethical concerns. Based on the above considerations, the European Academy of Paediatrics (EAP) and the European Confederation of Primary Care Pediatricians (ECPCP) assessed the current situation and presented recommendations for international and national authorities, pediatricians, and pediatric societies regarding vaccination against SARS-CoV-2 in children and adolescents.

Ejemplares similares